Caffeine intake during pregnancy and risk of problem behavior in 5- to 6-year-old children

Eva M Loomans1, Laura Hofland, Odin van der Stelt

  • 1Department of Psychology, Tilburg University, Warandelaan 2, 5037 AB Tilburg, Netherlands. e.m.loomans@uvt.nl

Pediatrics
|July 11, 2012
PubMed

Insights

Maternal caffeine intake during pregnancy did not increase children's behavioral issues by age five. This study suggests pregnant women need not reduce caffeine consumption to prevent behavioral problems in their offspring.

Area of Science:

  • Perinatal epidemiology
  • Developmental psychology
  • Maternal health

Background:

  • Research on caffeine intake during pregnancy and offspring behavior is limited and inconsistent.
  • Prospective investigation needed to clarify the association.

Purpose of the Study:

  • To examine the link between maternal caffeine consumption and children's behavioral outcomes at ages 5-6 years.
  • To explore potential mediation by fetal growth and gestational age.
  • To assess effect modification by child's gender and maternal smoking.

Main Methods:

  • A multiethnic birth cohort (n=8202) assessed maternal caffeine intake via self-report at 16 weeks gestation.
  • Children's behavior (problem behaviors, prosocial behavior) was rated by mothers and teachers at age 5 using the Strengths and Difficulties Questionnaire (n=3439).
  • Analyses controlled for various maternal and child factors, including prenatal anxiety and smoking.

Main Results:

  • Maternal caffeine intake during pregnancy showed no association with increased behavioral problems or decreased prosocial behavior in children.
  • No evidence supported mediation by fetal growth restriction or gestational age.
  • No effect modification was observed based on the child's gender.

Conclusions:

  • Intrauterine caffeine exposure does not appear to influence offspring's behavioral development at age 5.
  • Current findings do not support recommendations for pregnant women to limit caffeine intake to prevent behavioral issues in children.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is also...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...